Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Krueger, G.G.

Search results

  • RSS Feed
(1 - 7 of 7)
Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study
Kavanaugh, A.; Heijde, D. van der; Beutler, A.; Gladman, D.; Mease, P.; Krueger, G.G.; ... ; Xu, S. 2016
Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study
Article / Letter to editor
metadata only
Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)
Kavanaugh, A.; McInnes, I.B.; Mease, P.; Krueger, G.G.; Gladman, D.; Heijde, D. van der; ... ; Beutler, A. 2014
Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)
Article / Letter to editor
metadata only
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study
Kavanaugh, A.; McInnes, I.B.; Mease, P.J.; Krueger, G.G.; Gladman, D.D.; Heijde, D. van der; ... ; Beutler, A. 2013
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study
Article / Letter to editor
metadata only
5 Year Safety, Efficacy, and Radiographic Data in Patients with Active Psoriatic Arthritis Treated with Golimumab: Results From the Long-Term Extension of a Randomized, Placebo-Controlled Study
Kavanaugh, A.; Heijde, D. van der; McInnes, I.B.; Mease, P.; Krueger, G.G.; Gladman, D.; ... ; Beutler, A. 2012
5 Year Safety, Efficacy, and Radiographic Data in Patients with Active Psoriatic Arthritis Treated with Golimumab: Results From the Long-Term Extension of a Randomized, Placebo-Controlled Study
Article / Letter to editor
metadata only
Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial
Kavanaugh, A.; Heijde, D. van der; McInnes, I.B.; Mease, P.; Krueger, G.G.; Gladman, D.D.; ... ; Beutler, A. 2012
Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial
Article / Letter to editor
metadata only
GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY
Kavanaugh, A.; Heijde, D. van der; Chattopadhyay, C.; Gladman, D.; Mease, P.; McInnes, I.; ... ; GO-REVEAL Investigators 2011
GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY
Article / Letter to editor
metadata only
GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY
Kavanaugh, A.; Gladman, D.; Heijde, D. van der; Mease, P.; McInnes, L.; Krueger, G.G.; ... ; GO-REVEAL Investigators 2010
GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY
Other
metadata only